Overview Live Webcasts
Next Live Webcasts
Ingredientpharm - Neutral and Functional Starter Pellets
Starter Pellets are widely used for the formulation and manufacturing of multiparticulates. The characteristics of such pellets can play a vital role in development, scale up and manufacturing.
The webinar aims to cover those topics by example of CELLETS as a neutral starter pellet and TAP as a functional starter pellet.
Biogrund: The easy way of tableting: Excipient premixes for direct compression
What is important for a successful tableting formulation? What is the interaction between fillers, flow agents and binders?
We consider the necessary excipients that are needed for direct tableting. Among other things, we look at the properties of fillers and dry binders in detail and investigate how the use of excipient premixes can positive influence the tableting process and final product.
The Live-Webcast covers:
- Polymers for direct compression
- Dry binder premixes
- Case studies
- Complete tableting premixes
- Sustained release systems
- Q&A during the webcast
Roquette: Orally disintegrating tablets (ODTs) – overcoming your main challenges
WEBINAR: Orally disintegrating tablets (ODTs) – overcoming your main challenges
ODTs are an innovative way to handle the product lifecycle management, generate market differentiation and increase consumer interest, but challenges such as oral disintegration time and ODT stability still exist. Join us on this webinar during which we discuss the main challenges associated with the development of ODT products and how pharmaceutical manufacturers can overcome them
Glatt: Multiparticulates from matrix core pellets – GLATT CPS® Technology
Thursday, 16 July 2020 – 03:00 PM CEST
Multiparticulates such as micropellets, pellets, granules and mini-tablets represent modern and innovative technology platforms. Multiparticulates can provide a number of advantages compared with larger-sized monolithic forms such as tablets. Increasing compliance is achieved for children – from birth to adolescence – and elderly. Individually tailored drug release profiles for any API and site specific drug delivery allow for an optimized and safe therapeutic effect.